Search results for "Proguanil"

showing 2 items of 2 documents

DC polarographic reduction of chloroguanide hydrochloride.

1984

Chloroguanide hydrochloride, an antimalarial drug, shows one well-defined DC polarographic wave in Britton-Robinson buffered media. In the pH range 3–9 the observed reduction wave is related to the reduction of the two azomethine centers on the monoprotonated biguanide group (BH+). The effects of pH and other experimental variables on the limiting current and half-wave potentials as well as the reduction mechanism are discussed.

PolarographyBiguanidemedicine.drug_classChemistryProguanil HydrochlorideInorganic chemistryLimiting currentPharmaceutical ScienceDimethylformamideHydrogen-Ion ConcentrationReduction (complexity)DiffusionProguanilPh rangemedicineOxidation-ReductionPolarographyJournal of pharmaceutical sciences
researchProduct

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Proguanil Hydrochloride

2018

Abstract Literature data relevant to the decision to waive in vivo bioequivalence testing for the approval of generic immediate release solid oral dosage forms of proguanil hydrochloride are reviewed. To elucidate the Biopharmaceutics Classification System (BCS) classification, experimental solubility and dissolution studies were also carried out. The antimalarial proguanil hydrochloride, effective via the parent compound proguanil and the metabolite cycloguanil, is not considered to be a narrow therapeutic index drug. Proguanil hydrochloride salt was shown to be highly soluble according to the U.S. Food and Drug Administration, World Health Organization, and European Medicines Agency guide…

DrugCycloguanilProguanilmedia_common.quotation_subjectProguanil HydrochlorideAdministration OralPharmaceutical SciencePharmacologyBioequivalence030226 pharmacology & pharmacyDosage formExcipientsAntimalarials03 medical and health sciences0302 clinical medicineparasitic diseasesAnimalsHumansMedicineRegulatory sciencemedia_commonDosage Formsbusiness.industryBiopharmaceutics Classification SystemMalariaProguanilSolubilityTherapeutic Equivalency030220 oncology & carcinogenesisbusinessmedicine.drugJournal of Pharmaceutical Sciences
researchProduct